News
HSA Adverse Drug Reaction News 2020 Sept, Vol.22 No.2
Professionals
Allied Health Professionals
Dental Practitioners
Doctors
Nurses
Pharmacists
TCM Practitioners
23 December 2020
Access and read HSA's September 2020 bulletin which covers adverse events for health products and other news.
HSA Adverse Drug Reaction News 2020 Sept, Vol.22 No.2
The aim of the news bulletin is to increase the awareness of adverse events related to health products amongst healthcare professionals, and to promote adverse event reporting related to health products.
This issue includes the following topics:
Conditional approval of remdesivir (Veklury®) for COVID-19 infection in Singapore
Temporary suspension of sales of EsmyaTM(ulipristal acetate) Tablet 5mg
Risk of venous thromboembolism with tofacitinib
Risk of orofacial malformations associated with the use of ondansetron in early pregnancy
AE Case in Focus: Test Yourself